文献速递胸部CT

吸烟者肺气肿CT进展与死亡率的关系:COPDGene与ECLIPSE队列研究结果

Relationship between Emphysema Progression at CT and Mortality in Ever-Smokers: Results from the COPDGene and ECLIPSE Cohorts.
PubMed 文献 · Radiology · 2021-02-16

对COPDGene与ECLIPSE两项前瞻性观察研究进行二次分析,采用第15百分位肺密度(perc15)测量肺气肿进展,Cox回归显示perc15每年每加快下降1 g/L,COPDGene全因死亡率增加8%(HR 1.08),ECLIPSE增加6%(HR 1.06),COPDGene呼吸死亡率增加22%(HR 1.22)。

要点

  • 肺气肿进展用肺密度perc15下降速率评估,每年下降越快全因死亡风险越高。
  • COPDGene中全因死亡HR 1.08(95%CI 1.01-1.16,P=.03),ECLIPSE中HR 1.06(95%CI 1.00-1.13,P=.045)。
  • COPDGene中呼吸死亡HR 1.22(95%CI 1.13-1.31,P<.001)。

关键影像表现/征象

  • 肺气肿在CT上以肺密度perc15法测量,perc15下降速率反映肺气肿进展。

诊断标准与关键数值

  • perc15每年每加快下降1 g/L,COPDGene全因死亡HR 1.08(95%CI 1.01,1.16;P=.03),ECLIPSE全因死亡HR 1.06(95%CI 1.00,1.13;P=.045)。
  • COPDGene中相同perc15变化速率增加对应呼吸死亡HR 1.22(95%CI 1.13,1.31;P<.001)。

临床应用与阅片要点

  • 在吸烟者肺气肿患者中,CT随访测量perc15下降速率可用于评估肺气肿进展并与死亡风险关联。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background The relationship between emphysema progression and long-term outcomes is unclear. Purpose To determine the relationship between emphysema progression at CT and mortality among participants with emphysema. Materials and Methods In a secondary analysis of two prospective observational studies, COPDGene (clinicaltrials.gov, NCT00608764) and Evaluation of Chronic Obstructive Pulmonary Disease Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE; clinicaltrials.gov, NCT00292552), emphysema was measured at CT at two points by using the volume-adjusted lung density at the 15th percentile of the lung density histogram (hereafter, lung density perc15) method. The association between emphysema progression rate and all-cause mortality was analyzed by using Cox regression adjusted for ethnicity, sex, baseline age, pack-years, and lung density, baseline and change in smoking status, forced expiratory volume in 1 second, and 6-minute walk distance. In COPDGene, respiratory mortality was analyzed by using the Fine and Gray method. Results A total of 5143 participants (2613 men [51%]; mean age, 60 years ± 9 [standard deviation]) in COPDGene and 1549 participants (973 men [63%]; mean age, 62 years ± 8) in ECLIPSE were evaluated, of which 2097 (40.8%) and 1179 (76.1%) had emphysema, respectively. Baseline imaging was performed between January 2008 and December 2010 for COPDGene and January 2006 and August 2007 for ECLIPSE. Follow-up imaging was performed after 5.5 years ± 0.6 in COPDGene and 3.0 years ± 0.2 in ECLIPSE, and mortality was assessed over the ensuing 5 years in both. For every 1 g/L per year faster rate of decline in lung density perc15, all-cause mortality increased by 8% in COPDGene (hazard ratio [HR], 1.08; 95% CI: 1.01, 1.16; P = .03) and 6% in ECLIPSE (HR, 1.06; 95% CI: 1.00, 1.13; P = .045). In COPDGene, respiratory mortality increased by 22% (HR, 1.22; 95% CI: 1.13, 1.31; P < .001) for the same increase in the rate of change in lung density perc15. Conclusion In ever-smokers with emphysema, emphysema progression at CT was associated with increased all-cause and respiratory mortality. © RSNA, 2021 Online supplemental material is available for this article. See also the editorial by Lee and Park in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Ash SY, San José Estépar R, Fain SB, et al. Relationship between Emphysema Progression at CT and Mortality in Ever-Smokers: Results from the COPDGene and ECLIPSE Cohorts. Radiology. 2021. PMID: 33591891. doi:10.1148/radiol.2021203531

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。